(Q40800342)

23 September 2017

1 reference

title

Growth factors. Clinical implications in breast cancer (English)

1 reference

23 September 2017

Klijn JG

1

1 reference

23 September 2017

Berns PM

series ordinal

2

1 reference

23 September 2017

Bontenbal M

series ordinal

3

1 reference

23 September 2017

Foekens JA

series ordinal

4

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

Annals of the New York Academy of Sciences

23 September 2017

published in

1 reference

23 September 2017

volume

698

1 reference

23 September 2017

page(s)

85-101

1 reference

Cell biological factors associated with the response of breast cancer to systemic treatment

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Cathepsin D in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Cathepsin D in breast cancer: a tissue marker associated with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Clinical breast cancer, new developments in selection and endocrine treatment of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

c-erbB-2 oncogene as a prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Prognostic factors in human primary breast cancer: comparison of c-myc and HER2/neu amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Predictors of hormone response for patients with ER-unknown breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17193.X

10.1111/J.1749-6632.1993.TB17193.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference